Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Real-World Evidence: Lessons From GSK's Salford Lung Study

Executive Summary

The Salford Lung Study is pioneering in the emerging field of gathering real-world evidence. David Leather, Global Medical Affairs Leader in the Respiratory Franchise at GSK, led the UK-based study and talked to the Pink Sheet about why it was important for GSK and what may come next.

Advertisement

Related Content

Real World Evidence Is Critical To Pharma’s Future: Can We Agree On What It Is?
Real-World Evidence And The Quest For European Market Access
How To Successfully Strategize Real World Evidence For Market Access
Profile: GSK's David Leather On Transitioning from GP And Radio Doctor to Real World Evidence Tsar
GSK's David Leather On Transitioning from GP And Radio Doctor To Real World-Evidence Czar

Topics

Related Companies

Related Deals

Advertisement
UsernamePublicRestriction

Register

PS119099

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

All set! This Question has been sent to my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel